About Weston Park
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Judith Dixon-Hughes
2
Cheryl Pugh
1
International Extranodal Lymphoma Study Group (IELSG)
1
Professor David Cunningham
1
University of Birmingham
1
Clinical Trials at Weston Park
During the past decade, Weston Park conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma
2003-01-01
2016-02-17
Completed
454
Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
2007-10-01
2017-12-01
Unknown status
1,103
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
2007-07-01
2015-09-01
Completed
169
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
2019-08-28
2023-02-28
Active, not recruiting
35
PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer
2017-11-28
2026-01-31
Recruiting
500
Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer
2017-11-28
2025-12-31
Recruiting
2,500
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Weston Park" #1 sponsor was "Judith Dixon-Hughes" with 2 trials, followed by "Cheryl Pugh" with 1 trials
sponsored, "International Extranodal Lymphoma Study Group (IELSG)" with 1 trials sponsored, "Professor David Cunningham" with 1 trials sponsored and "University of Birmingham"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Weston Park"
#1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Weston Park
According to Clinical.Site data, the most researched conditions in "Weston Park" are
"Colorectal Cancer" (2 trials), "Neoplasms Pancreatic" (2 trials), "Lymphoma, Mucosa-Associated Lymphoid Tissue" (1 trials) and "Oesophagogastric Cancer" (1 trials). Many other conditions were trialed in "Weston Park" in a lesser frequency.
Clinical Trials Intervention Types at Weston Park
Most popular intervention types in "Weston Park" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "capecitabine" (2 trials), "Epirubicin" (1 trials), "FOLFOX-A" (1 trials), "G-CSF" (1 trials) and "Gemcitabe and Abraxane" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Weston Park
The vast majority of trials in "Weston Park" are
6 trials for "All" genders.
Clinical Trials Status at Weston Park
Currently, there are NaN active trials in "Weston Park".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Weston Park,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Weston Park, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".